Peer Review reports
From: Phase I dose-escalation oncology trials with sequential multiple schedules
| Original Submission | ||
|---|---|---|
| 25 Aug 2020 | Submitted | Original manuscript |
| 27 Aug 2020 | Author responded | Author comments - Burak Kürsad Günhan |
| Resubmission - Version 2 | ||
| 27 Aug 2020 | Submitted | Manuscript version 2 |
| 29 Oct 2020 | Reviewed | Reviewer Report |
| 8 Dec 2020 | Reviewed | Reviewer Report |
| 8 Jan 2021 | Author responded | Author comments - Burak Kürsad Günhan |
| Resubmission - Version 3 | ||
| 8 Jan 2021 | Submitted | Manuscript version 3 |
| 18 Jan 2021 | Reviewed | Reviewer Report |
| 22 Jan 2021 | Author responded | Author comments - Burak Kürsad Günhan |
| Resubmission - Version 4 | ||
| 22 Jan 2021 | Submitted | Manuscript version 4 |
| Publishing | ||
| 26 Jan 2021 | Editorially accepted | |
| 14 Apr 2021 | Article published | 10.1186/s12874-021-01218-9 |
You can find further information about peer review here.